+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Search for: Neuropathy%20Therapy%20Area%20Pipeline%20Report

Europe Diabetic Foot Ulcer Treatment Market, Competition, Forecast & Opportunities, 2018-2028 - Product Thumbnail Image

Europe Diabetic Foot Ulcer Treatment Market, Competition, Forecast & Opportunities, 2018-2028

  • Report
  • October 2023
  • 128 Pages
  • Europe
From
Global Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report by Disorder Type (Peripheral Neuropathy, Autonomic Neuropathy), Drug Class (NSAIDs, Capsaicin, Opioid), Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Global Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report by Disorder Type (Peripheral Neuropathy, Autonomic Neuropathy), Drug Class (NSAIDs, Capsaicin, Opioid), Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • March 2024
  • 150 Pages
  • Global
From
Global Peripheral Neuropathy Treatment Market 2023-2027 - Product Thumbnail Image

Global Peripheral Neuropathy Treatment Market 2023-2027

  • Report
  • November 2022
  • 120 Pages
  • Global
From
Neurological Diseases Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Neurological Diseases Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 142 Pages
  • Global
From
Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

  • Report
  • November 2021
  • 600 Pages
  • Global
From
Diabetic Neuropathic Pain Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Diabetic Neuropathic Pain Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • February 2023
  • 127 Pages
  • Global
From
Global Neuropathic Pain Drug Market by Type (Phantom Limb Pain, Post Herpetic Neuralgia, Post-traumatic Neuropathy), Treatment (Antidepressant Drugs Type, Multimodal Therapy, NSAIDs Type), Indication, Distribution, End User - Forecast 2024-2030 - Product Thumbnail Image

Global Neuropathic Pain Drug Market by Type (Phantom Limb Pain, Post Herpetic Neuralgia, Post-traumatic Neuropathy), Treatment (Antidepressant Drugs Type, Multimodal Therapy, NSAIDs Type), Indication, Distribution, End User - Forecast 2024-2030

  • Report
  • March 2024
  • 196 Pages
  • Global
From
Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 83 Pages
  • Global
From
Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 51 Pages
  • Global
From
Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 65 Pages
  • Global
From
Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 85 Pages
  • Global
From
Mitochondrial Disease Therapies Market, 2019-2030 - Product Thumbnail Image

Mitochondrial Disease Therapies Market, 2019-2030

  • Report
  • July 2019
  • 250 Pages
  • Global
From
Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 56 Pages
  • Global
From
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 151 Pages
  • Global
From
Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 159 Pages
  • Global
From
Familial Amyloid Neuropathies - Pipeline Review, H1 2020 - Product Thumbnail Image

Familial Amyloid Neuropathies - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 98 Pages
  • Global
From
Back of the Eye Disorders: Novel Drugs and Delivery Technologies, 2017-2030 - Product Thumbnail Image

Back of the Eye Disorders: Novel Drugs and Delivery Technologies, 2017-2030

  • Report
  • January 2018
  • 292 Pages
  • Global
From
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 138 Pages
  • Global
From
Cell and Gene Therapies in Rare Disorders - Market Insights, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Cell and Gene Therapies in Rare Disorders - Market Insights, Epidemiology and Market Forecast - 2032

  • Report
  • April 2023
  • 399 Pages
  • Global
From
Leber s Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline Review, H2 2018 - Product Thumbnail Image

Leber s Hereditary Optic Neuropathy (Leber Optic Atrophy) - Pipeline Review, H2 2018

  • Drug Pipelines
  • September 2018
  • 86 Pages
  • Global
From
Loading Indicator